Quant Business Cycle Fund - Growth - Regular Plan

Other Plans and Options
  • 0.86 %Nav, as on 07-11-2025

  • Previous Nav

  • Net Change on 07-11-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To generate long-term capital appreciation by investing with focus on riding business cycles through allocation between sectors and stocks at different stages of business cycles. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The scheme does not assure or guarantee any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
NIFTY 500 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
UTI-Transpotation and Logistics Fund-Growth Option Apr 16, 2004 13.04 22.69 26.24 1.91 4,008.33
Quant ESG Integration Strategy Fund - Growth Option - Regular Plan Nov 05, 2020 -5.15 13.76 26.82 2.42 273.90

Fund Holdings as on 31-October-2025

  • TREPS 03-Nov-2025 DEPO 10

  • Jio Financial Services Limited

  • Samvardhana Motherson International Ltd

  • Reliance Industries Limited 25/11/2025

  • HFCL Limited

  • Aurobindo Pharma Limited

  • S. P. Apparels Limited

  • Piramal Finance Ltd

  • Adani Green Energy Limited

  • Alivus Life Sciences

  • SUN TV Network Limited

  • Indian Oil Corp Ltd

  • Zydus Wellness Ltd

  • Tata Power Company Limited

  • Aurobindo Pharma Limited 25/11/2025

  • ANTHEM BIOSCIENCES LIMITED

  • Bajaj Auto Limited 25/11/2025

  • BROOKS Laboratories Limited

  • Life Insurance Corporation Of India

  • Strides Pharma Science Ltd

  • Kovai Medical Center & Hospital Ltd.

  • Bajaj Auto Limited

  • 91 Days Treasury Bill 18-Dec-2025

  • Aditya Birla Lifestyle Brands Limited

  • Adani Enterprises Limited

  • 91 Days Treasury Bill 28-Nov-2025

  • 91 Days Treasury Bill 04-Dec-2025

  • 91 Days Treasury Bill 02-Jan-2026

  • 91 Days Treasury Bill 15-Jan-2026

  • 91 Days Treasury Bill 23-Jan-2026

  • 91 Days Treasury Bill 29-Jan-2026

  • 91 Days Treasury Bill 20-Nov-2025

  • 91 Days Treasury Bill 08-Jan-2026

  • NCA-NET CURRENT ASSETS

View More

  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Finance - NBFC

  • Power Generation/Distribution

  • Auto Ancillary

  • Telecom-Infrastructure

  • Textile

  • Finance - Housing

  • TV Broadcasting & Software Production

  • Refineries

  • Consumer Food

  • Insurance

  • Hospital & Healthcare Services

  • Automobile Two & Three Wheelers

  • Retailing

  • Trading

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • SOV

View More

About Quant Business Cycle Fund

Scheme Analysis

Quant Business Cycle Fund is a Equity - Thematic Fund - Other fund and belongs to Quant Mutual Fund. It was launched on 30-May-2023 and currently has an AUM of ₹1,154.66 crore. Quant Business Cycle Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY 500 - TRI as secondary index.

The NAV of Quant Business Cycle Fund ended up ₹0.13(0.86%)yesterday to ₹15.5498.

Among its top 3 holdings the fund has exposure to TREPS 03-Nov-2025 DEPO 10, and

The Quant Business Cycle Fund is managed by Ankit Pande and Sandeep Tandon.

Fund House Contact

6th Floor, Sea Breeze Building, Appa Saheb Marathe Marg, Prabhadevi, Mumbai - 400025

022-6295 5000
help@quant.in
022-6295 5000